Patents by Inventor Boris Pinchuk

Boris Pinchuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THYMIDINE KINASE (TK-1) IN PROGNOSTIC INDICES FOR DLBCL
    Publication number: 20210199659
    Abstract: The present disclosure relates to the finding that thymidine kinase 1 (TK-1) represents a valuable biomarker in a method for determining a Prognostic Index (PI) for risk stratification of a patient with aggressive B-cell lymphoma, especially diffuse large B-cell lymphoma (DLBCL), to the use of TK-1 in such PI and to a PI comprising the marker TK-1.
    Type: Application
    Filed: February 26, 2021
    Publication date: July 1, 2021
    Inventors: Vinzent Rolny, Sandra Rutz, David Morgenstern, Boris Pinchuk, Christina Zimmermann, Martin Klammer, Franziska Sonner
  • NOVEL ANTI-THYMIDINE KINASE ANTIBODIES
    Publication number: 20210061924
    Abstract: The present invention relates to a novel monoclonal antibody that specifically binds to a conformation dependent epitope on human thymidine kinase 1 (hTK-1; SEQ ID NO:1), to methods for quantifying hTK-1 employing the antibody and to the use of the anti-hTK-1 antibody in quantifying hTK-1.
    Type: Application
    Filed: October 13, 2020
    Publication date: March 4, 2021
    Inventors: Hartmut Duefel, Alfred Engel, Frank Kroner, Thomas Meier, Sandra Rutz, Michael Schraeml, Gloria Tabares, Ulrike Kurtkaya, Boris Pinchuk, Christina Zimmermann